Medication info
H-Position 5/80 mg (Amlodipine Besylate, Valsartan)

H-Position 5/80 mg (Amlodipine Besylate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
28 tablets (14 tablets/Alu-Alu * 2)
Approval status
Active

MFDS item code 201704024 · Approved 2017.06.19 · Insurance code 642005090

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, direct switching to this medication may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows: ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Exercise caution when increasing the dose.
Child dose
Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used as an additional treatment option when blood pressure is not adequately controlled with either amlodipine or valsartan alone for the treatment of essential hypertension. It is important to maintain stable blood pressure to prevent cardiovascular complications, and this medication helps control blood pressure and improve health.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, direct switching to this medication may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows: ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Exercise caution when increasing the dose.

Child dose

Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious damage to the fetus and newborn in the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. People with allergies to any of the ingredients in this medication, pregnant or breastfeeding women, and individuals with severe kidney or liver disease should not take this medication. Individuals who are deficient in sodium or fluids may experience low blood pressure, so it is important to check their condition before starting treatment, and physician supervision is necessary at the beginning. Patients with high potassium levels should use caution when taking this medication and other drugs that may increase potassium, and frequent monitoring of serum potassium levels is required. Individuals with problems in renal blood vessels or those who have received a kidney transplant should use this medication cautiously, as kidney function may change during treatment. If symptoms of angioedema occur, this medication should be discontinued immediately and should not be readministered. Patients with heart failure or those recovering from myocardial infarction should closely monitor kidney function while taking this medication, as pulmonary edema may occur, hence physician guidance is essential. Caution is also advised due to potential dizziness or fatigue while driving or operating machinery. Overdose of this medication can result in serious side effects such as low blood pressure or increased heart rate; thus, immediate medical attention should be sought in cases of overdose. Interactions may occur when combined with other medications, so it is essential to inform the physician or pharmacist of any current medications. Children under the age of 18 should not be administered this medication, as its safety and efficacy have not been fully established in this population. Elderly patients may use similar dosages as general adults; however, a physician's discretion is necessary based on their condition.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle cramps, malaise, polyuria, nocturia, erectile dysfunction, edema, dependent edema, facial swelling, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disorder, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary incontinence, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, sensory loss, Stevens-Johnson syndrome, dizziness, fatigue, hypotension, reflex tachycardia, non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the efficacy of the medication.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

28 tablets (14 tablets/Alu-Alu * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.